Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group

Author： Hakamies-Blomqvist L.   Luoma M.-L.   Sjostrom J.   Pluzanska A.   Sjodin M.   Mouridsen H.   Ostenstad B.   Mjaaland I.   Ottosson-Lonn S.   Bergh J.   Malmstrom P.-O.   Blomqvist C.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.11, 2000-07, pp. : 1411-1417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group - a nonrandomized pilo

By Sjostrom J.   Blomqvist C.   Mouridsen H.   Pluzanska A.   Ottosson-Lonn S.   Bengtsson N.-O.   Ostenstad B.   Mjaaland I.   Palm-Sjovall M.   Wist E.   Valvere V.   Anderson H.   Bergh J.  

European Journal of Cancer, Vol. 35, Iss. 8, 1999-08 ,pp. : 1194-1201

Elsevier

Access to resources Recommend Favorite

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

By Sjostrom J.   Collan J.   von Boguslawski K.   Franssila K.   Bengtsson N.-O.   Mjaaland I.   Malmstrom P.   Ostenstad B.   Wist E.   Valvere V.   Bergh J.   Skiold-Petterson D.   Saksela E.   Blomqvist C.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

By Helsing M.   Bergman B.   Thaning L.   Hero U.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1036-1044

Elsevier

Access to resources Recommend Favorite

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer

By Amadori Dino   Silvestrini Rosella   Lena Mario   Boccardo Francesco   Rocca Andrea   Scarpi Emanuela   Schittulli Francesco   Brandi Mario   Maltoni Roberta   Serra Patrizia   Ponzone Riccardo   Biglia Nicoletta   Gianni Lorenzo   Tienghi Amelia   Valerio Maria   Bonginelli Paola   Amaducci Laura   Faedi Marina   Baldini Editta   Paradiso Angelo  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 775-784

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy - a phase I, dose-finding study

By Lortholary A.   Maillard P.   Delva R.   Boisdron-Celle M.   Perard D.   Vernillet L.   Besenval M.   Gamelin E.  

European Journal of Cancer, Vol. 36, Iss. 14, 2000-09 ,pp. : 1773-1780

Elsevier

Access to resources Recommend Favorite